Local alignment of ligand binding sites in proteins for polypharmacology and drug repositioning by Brylinski, Michal
Louisiana State University 
LSU Digital Commons 
Faculty Publications Department of Biological Sciences 
1-1-2017 
Local alignment of ligand binding sites in proteins for 
polypharmacology and drug repositioning 
Michal Brylinski 
Louisiana State University 
Follow this and additional works at: https://digitalcommons.lsu.edu/biosci_pubs 
Recommended Citation 
Brylinski, M. (2017). Local alignment of ligand binding sites in proteins for polypharmacology and drug 
repositioning. Methods in Molecular Biology, 1611, 109-122. https://doi.org/10.1007/
978-1-4939-7015-5_9 
This Article is brought to you for free and open access by the Department of Biological Sciences at LSU Digital 
Commons. It has been accepted for inclusion in Faculty Publications by an authorized administrator of LSU Digital 
Commons. For more information, please contact ir@lsu.edu. 
Local alignment of ligand binding sites in proteins for 
polypharmacology and drug repositioning
Michal Brylinski1,2,*
1Department of Biological Sciences, Louisiana State University, Baton Rouge, LA
2Center for Computation & Technology, Louisiana State University, Baton Rouge, LA
Summary
The administration of drugs is a key strategy in pharmacotherapy to treat diseases. Drugs are 
typically developed to modulate the function of specific proteins, which are directly associated 
with particular disease states. Nonetheless, recent studies suggest that protein-drug interactions are 
rather promiscuous and the majority of pharmaceuticals exhibit activity against multiple, often 
unrelated proteins. Certainly, the lack of selectivity often leads to drug side effects; on the other 
hand, these polypharmacological attributes can be used to develop drugs acting on multiple targets 
within a unique disease pathway, as well as to identify new targets for existing drugs, which is 
known as drug repositioning. To support drug development and repurposing, we developed 
eMatchSite, a new approach to detect those binding sites having the capability to bind similar 
compounds. eMatchSite is available as a standalone software and a webserver at http://
www.brylinski.org/ematchsite.
Keywords
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1. Introduction
Network analysis of interactions between proteins and small organic compounds is broadly 
applicable throughout the drug development process in both biology and chemistry. The 
classical picture of selective ligand binding has been challenged by experimental and 
computational studies, which strongly suggest that the space of protein-ligand interactions is 
dense and highly connected [1]. Several independent studies were conducted to estimate the 
promiscuity of protein-ligand interactions. For example, a large-scale across-target activity 
analysis carried out for 189,807 active compounds from PubChem [2] shows that the 
majority (62%) of them exhibit activity against multiple, often unrelated targets [3]. Another 
study investigating a set of 3,138 compounds against 79 targets reported that 47% of the 
compounds can be classified as “promiscuous” and 24% as “highly promiscuous” with 
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of 5,215 protein-ligand interactions connecting 829 compounds with 557 targets estimated 
that the average number of target proteins per ligand is 6.3 [5]. Although this notable 
binding promiscuity may complicate drug development, it also creates appealing 
opportunities for polypharmacology and drug repurposing.
Classical algorithms detecting relationships between proteins widely used in bioinformatics 
cannot be applied to investigate drug cross-reactivity because many compounds bind to 
multiple proteins that are totally unrelated to each other at the global sequence and structure 
levels [6, 7]. Therefore, a comprehensive analysis of the protein-drug interaction space 
requires a different set of tools. A direct comparison of binding sites is capable of describing 
ligand binding at the molecular level to provide useful insights into the compound mode of 
action [8]. Most algorithms for binding site matching fall into two categories: alignment-free 
and alignment-based methods. Geometric hashing is a typical example of the alignment-free 
approach; it measures the overall similarity of two binding sites, however, without providing 
any structural information on putative ligand binding modes and molecular interactions with 
target proteins [9]. In contrast, methods based on binding site alignments elucidate why two 
sites are similar, identify the sets of atoms/residues that contribute to the similarity, and 
describe putative ligand binding modes. SuMo (Surfing the Molecules) was one of the first 
approaches to use a residue-independent stereochemical group description combined with a 
fast, graph-based algorithm to compare protein structures and substructures [10]. Another 
method, SiteEngine, matches low-resolution protein surfaces constructed by converting 
triangles of physicochemical properties into a discrete set of chemically important points 
[11]. Finally, SOIPPA performs sequence order-independent profile-profile alignments of 
binding pockets using a coarse-grained representation of protein structures [12].
Despite encouraging progress in the development of sequence order-independent algorithms 
for ligand binding site alignment, many of these approaches perform well only against high-
quality binding sites extracted from experimental protein structures. This insufficient 
accuracy hinders the reconstruction of protein-drug interaction networks across proteomes; 
thus, it is imperative to develop new approaches insensitive to structural deformation in 
ligand binding regions of protein models. To mitigate this issue, we developed eMatchSite, a 
new algorithm that performs sequence order-independent local binding site alignments using 
computer-generated protein models [13]. A key feature responsible for its high performance 
is the extensive use of evolutionary information that can be extracted even from weakly 
homologous templates complexed with ligands. In addition, eMatchSite provides a 
calibrated significance score to identify those pockets capable of binding chemically similar 
ligands regardless of any global sequence and structure similarities between the target 
proteins. Benchmarking calculations demonstrate that eMatchSite outperforms other 
algorithms constructing sequence order-independent alignments of ligand binding sites. 
Importantly, eMatchSite maintains its high prediction accuracy against protein models, 
therefore, it opens up the possibility to investigate drug-protein interactions for complete 
proteomes with prospective systems-level applications in polypharmacology and rational 
drug repositioning.
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Input data for eMatchSite consist of two protein structures in the Protein Data Bank (PDB) 
format, whose ligand binding sites were annotated by eFindSite (see Note 1). eFindSite is a 
ligand binding site prediction and virtual screening algorithm that detects common ligand 
binding sites in a set of evolutionarily related proteins identified by meta-threading [14, 15]. 
In order to perform binding site annotation with eFindSite, users can employ either its 
standalone version or webserver located at http://www.brylinski.org/efindsite (see Note 2). It 
is noteworthy that both eFindSite and eMatchSite work well not only with experimentally 
solved structures, but also with computer-generated protein models (see Note 3).
2.2. Programs Used
eMatchSite is written in C++ and requires the following libraries: zlib (www.zlib.net), 
gzstream (www.cs.unc.edu/Research/compgeom/gzstream), and libsvm 
(www.csie.ntu.edu.tw/~cjlin/libsvm). In addition, eMatchSite requires a compound library, 
which is available at http://www.brylinski.org/content/ematchsite-standalone-package. 
Below, we describe options for running the standalone version of eMatchSite.
Input options— -i input_file, where input_file is a single text file providing the 
location of all data files required by eMatchSite. Each line should contain only one keyword 
followed by a space and the path to the input file. Lines starting with # are ignored. List of 
keywords ( A – first protein, B – second protein):
• structureA and structureB – target structures in the PDB format
• profilesA and profilesB – sequence profiles
• secstrA and secstrB – secondary structure profiles
• pocketsA and pocketsB – eFindSite pockets
• numberA and numberB – eFindSite pocket numbers (default 1)
1Although the current version of eMatchSite requires ligand binding sites to be annotated by eFindSite, we are working on other 
prediction protocols to compare binding pockets detected by purely geometrical methods. Nonetheless, eFindSite was demonstrated to 
outperform many other algorithms in large-scale benchmarking calculations, therefore, the combination of eFindSite/eMatchSite 
works best in detecting similar binding sites across large datasets of protein structures. Since eFindSite typically detects more than one 
site for the majority of proteins, users may want to specify the binding site of interest if they plan to run eMatchSite for a handful of 
targets. In large-scale applications, the top-ranked binding sites should be used by default because eFindSite ranks the best pocket at 
rank 1 in about 80% of the cases.
2Web portals for eFindSite and eMatchSite are intended to study selected proteins and their binding site similarities. However, both 
tools also have standalone versions that can be installed locally for high-throughput computations across large datasets of protein 
structures. Our website provides open source codes, the required template libraries, as well as detailed installation instructions and 
manuals to help users deploy eFindSite and eMatchSite on their computing systems. It is noteworthy that in addition to a serial code, 
eFindSite was ported to parallel accelerators in order to accelerate binding site annotations using heterogeneous computing systems 
[31, 32].
3Both eFindSite and eMatchSite have been designed to work not only with experimental ligand-bound (holo) and ligand-free (apo) 
target structures, but also with computer-generated protein models. Compared to crystal structures, the accuracy of eFindSite 
predicting binding residues in high- and moderate-quality structure models decreases only by 4.2% and 9.9%, respectively [14]. 
Similarly, eMatchSite also maintains its capability to construct highly accurate alignments when protein models are used. Depending 
on the model quality, the percentage of correctly aligned binding sites is only 4–9% lower than those aligned using crystal structures 
[13]. On that account, binding site similarities can be effectively detected using homology models generated across proteomes by 
contemporary protein structure prediction techniques.
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• alignmentsA and alignmentsB – eFindSite alignments
• ligandsA and ligandsB – eFindSite ligands
Alternatively, users can specify the path to individual data files from command line. For 
example, the following arguments can be used to provide the location of target structures:
-structureA first_pdb, where first_pdb is the first protein in the PDB 
format,
-structureB second_pdb, where second_pdb is the second protein in the PDB 
format.
The path to other input data can be specified in a similar way.
Output options
-o output_name, where output_name is a PDB file containing all results from 
eMatchSite.
Virtual screening options
-m score_func, where score_func is a scoring function to perform ligand-based 
virtual screening. Currently implemented functions include single and combined 
scores (see [15] for details):
Single scoring functions
tst – classical Tanimoto coefficient for Daylight fingerprints,
tsa – average Tanimoto coefficient for Daylight fingerprints,
tsc – continuous Tanimoto coefficient for Daylight fingerprints,
tmt – classical Tanimoto coefficient for MACCS fingerprints,
tma – average Tanimoto coefficient for MACCS fingerprints,
tmc – continuous Tanimoto coefficient for MACCS fingerprints.
Combined scoring functions
sum – data fusion using the sum rule (default),
max – data fusion using the max rule,
min – data fusion using the min rule,
svm – machine learning using Support Vector Machines.
Output files—eMatchSite outputs a single file that contains 1) numerical scores for the 
constructed alignment of binding sites, 2) aligned residue pairs with the corresponding Cα-
Cα distances, 3) transformation matrices to superpose the second protein onto the first 
protein, and 4) the coordinates of the second protein upon the superposition of two binding 
sites.
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The webserver available at http://www.brylinski.org/ematchsite provides a convenient 
interface to run eMatchSite. In addition, the website provides a standalone package that can 
be installed locally for high-throughput computations, benchmarking datasets and results for 
an easy comparison with other algorithms constructing local alignments of binding sites, as 
well as a detailed manual and tutorial to help run eMatchSite.
3. Methods
3.1. Web Submission Form
The submission form for the eMatchSite webserver requires two target pockets annotated by 
eFindSite. Fig. 1 shows that users need to provide a 10-digit eFindSite ticket for each target 
and specify the pocket number if multiple pockets are identified in the target structure. In 
addition, each submission requires a unique “Job ID” and, optionally, an email address 
where the results will be sent. If a user prefers not to use email notifications, the 
automatically generated 10-digit ticket for each submission can be used to check the job 
status using the “Job Tracking” form in the right sidebar at http://www.brylinski.org.
3.2. Result Page
Results generated by the eMatchSite webserver are arranged into several sections as shown 
in Fig. 2. The first section (Fig. 2a) gives the general information including the “Job ID”, the 
“eMatchSite ticket” that can be used to retrieve the results within a month from the 
submission date, and the identifiers of protein targets. Further, three numerical scores for the 
local alignment of binding sites are provided, including the alignment score ranging from 0 
to 1, the number of aligned residues, and the Cα-RMSD calculated upon the superposition 
of target pockets. Based on the alignment score, the similarity of the pair of target pockets is 
determined. The superposition of target binding sites is visualized using the AstexViewer 
web applet [16] (Fig. 2b). Here, protein structures are displayed as transparent cartoons, 
whereas binding residues are shown as solid sticks. Moreover, individual aligned residue 
pairs can be highlighted and labeled using radio buttons. The next section contains a table 
showing the local alignment of binding sites (Fig. 2c). For each aligned residue pair, the Cα-
Cα distance measured upon the local superposition, as well as the Cα-Cα distance and the 
probability score estimated by machine learning are listed. Finally, the last section provides 
a download link to the output file generated by eMatchSite (Fig. 2d).
Note that the results are kept on the server for one month only, after which all data 
associated with a particular submission will be deleted. However, we keep one sample job 
for each webserver, so that users can quickly find out whether the webservers offer a desired 
functionality. These sample results can be accessed anytime either by clicking on links 
provided in the submission web forms, e.g. “This server is running eMatchSite v1.0. Click 
here to see some sample results”, or by using 10-digit tickets, “Futermylok” for eFindSite 
and “Mamlasiaty” for eMatchSite, in the “Job Tracking” form in the right sidebar.
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We selected a couple of illustrative examples to demonstrate how eMatchSite detects those 
pockets binding similar ligands in non-homologous proteins by constructing the sequence-
order independent alignments of their binding sites. The primary target is benzoylformate 
decarboxylase (BFD) from Pseudomonas putida complexed with thiamin-2-thiazolone 
diphosphate (PDB-ID: 1yno) [17]. BFD belongs to the family of enzymes dependent on 
thiamine diphosphate and catalyzes the conversion of benzoylformate to benzaldehyde and 
carbon dioxide. Thiamin-2-thiazolone diphosphate (ThTDP) is a potent inhibitor of several 
thiamin-dependent enzymes that initiate the catalyzed reactions by forming a covalent 
adduct between the substrate and thiamin diphosphate (ThDP) through the C2 atom of the 
thiazolium ring [18]. In ThTDP, the proton on C2 is replaced with an oxygen atom to 
effectively inactivate thiamin-dependent enzymes. ThTDP binds to its target enzymes with 
an essentially identical binding mode as ThDP, but at a 10–1,000 higher affinity compared to 
ThDP [19–21].
In addition to the primary target BFD, we selected two off-targets known to bind ThTDP, 
oxalyl-coenzyme A decarboxylase from Oxalobacter formigenes (OXC, PDB-ID: 2c31) [22] 
and the dehydrogenase/decarboxylase component of the human branched-chain α-ketoacid 
dehydrogenase complex (hE1b, PDB-ID: 2bff) [23]. OXC plays an important role in the 
catabolism of the highly toxic compound oxalate and it is structurally similar to BFD with a 
TM-score [24] of 0.85 despite a low sequence identity of 25% (Table 1, Global similarity). 
hE1b, which catalyzes the decarboxylation of branched-chain α-ketoacids derived from the 
amino acids leucine, isoleucine, and valine, shares neither sequence nor structure similarity 
with BFD (Table 1, Global similarity). Both off-targets represent a challenge to local binding 
site alignment algorithms due to their low sequence homology with the primary target, BFD.
eMatchSite requires binding sites and residues to be annotated by eFindSite, therefore, 
eFindSite webserver at http://www.brylinski.org/efindsite was used to identify binding sites 
in the crystal structures of BFD, OXC and hE1b. The results are shown in Fig. 3. A binding 
site for ThTDP in the primary target BFD was identified with a 95% confidence; Matthew’s 
correlation coefficient (MCC) calculated over binding residues is as high as 0.89 (Fig. 3a). 
The prediction confidence for off-targets OXC and hE1b is 94% and 93%, respectively. 
MCC calculated for binding residues identified in OXC is 0.78 (Fig. 3b) and 0.88 for hE1b 
(Fig. 3c). Note that bound ThTDP ligands are shown in Fig. 3 only to assess the accuracy of 
binding pocket prediction with eFindSite, which detects and annotates binding sites in 
ligand-free protein structures [14, 15].
Despite a low homology between the primary target and off-targets, binding sites in both 
OXC and hE1b are correctly recognized by eMatchSite as highly similar to the ThTDP-
binding site in BFD, indicated by a confidence of 93% and 94%, respectively. Using data 
reported by eMatchSite, we can analyze how these high similarity scores were calculated. 
eMatchSite constructs sequence order-independent alignments using machine learning with 
Support Vector Regression techniques (SVR). Specifically, it assigns SVR scores to all 
possible combinations of binding residues in the first (target) and the second (off-target) 
protein. Then, it applies the Kuhn-Munkres algorithm [25, 26] to identify a unique set of 
residue pairs that give the shortest overall distance between their Cα atoms. The Kuhn-
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Munkres algorithm, also known as the Hungarian method, belongs to the complexity class P 
[27], efficiently solving combinatorial assignment problems in polynomial time. In 
eMatchSite, this algorithm produces sequence orderindependent alignments whose sum of 
Cα-Cα distances is guaranteed to be the smallest amongst all possible alignment 
combinations.
Clearly, a high correlation between Cα-Cα distances estimated by machine learning (SVR 
scores) and real distances calculated upon the superposition of bound ThTDP molecules is a 
critical factor to produce correct alignments. Encouragingly, light gray circles in Fig. 4 
demonstrate that the machine learning model implemented in eMatchSite accurately predicts 
Cα-Cα distances; the Pearson correlation coefficients for BFD/OXC (Fig. 4a) and BFD/
hE1b (Fig. 4b) are as high as 0.98 and 0.94, respectively. As a consequence, the unique sets 
of residue pairs selected by the Kuhn-Munkres algorithm to yield the shortest overall Cα-
Cα distance actually correspond to the reference alignments constructed by superposing 
ThTDP molecules bound to the primary target and off-targets (dark gray triangles in Fig. 4). 
Bear in mind that ThTDP ligands bound to BFD, OXC and hE1b are used only to validate 
alignments generated by eMatchSite that employs binding pockets annotated by eFindSite in 
ligand-free target structures.
Geometrical and physicochemical matching of binding sites in eMatchSite is supported by a 
chemical correlation, which was originally devised to study the inhibitor cross-reactivity 
within the human kinome [28]. In essence, a fingerprint-based virtual screening is performed 
against two pockets using a non-redundant subset of the ZINC library [29] comprising 
23,659 molecules. Subsequently, the Kendall τ rank correlation coefficient [30] is calculated 
for the ranked compounds under the assumption that virtual screening should yield a similar 
ranking for those pockets binding similar compounds. Indeed, Fig. 5 shows a high chemical 
correlation between binding sites in the primary and off-targets selected for this case study. 
The Kendall τ rank correlation coefficient is 0.98 between BFD and OXC (Fig. 5a), and 0.81 
between BFD and hE1b (Fig. 5b).
Sequence order-independent alignments constructed by eMatchSite for BFD/OXC and BFD/
hE1b are reported in Table 2. 16 residues are involved in the alignment between BFD and 
OXC, and 15 residues in that between BFD and hE1b; in both cases, the distances between 
the aligned Cα atoms upon the superposition of binding sites are fairly short. Binding 
pockets in off-targets superposed onto the pocket in the primary target structure are shown in 
Fig. 6. Table 1 (Local similarity) reports the RMSD calculated over Cα atoms of 3.18 Å for 
BFD/OXC (Fig. 6a) and 2.72 Å for BFD/hE1b (Fig. 6b). The accuracy of alignments 
constructed by eMatchSite can be evaluated by an RMSD calculated over the non-hydrogen 
atoms of ThTDP molecules upon the superposition of binding residues. Encouragingly, 
Table 1 (Local similarity) shows that the ligand RMSD is as low as 0.88 Å for BFD/OXC 
(Fig. 6c) and 0.89 Å for BFD/hE1b (Fig. 6b). Overall, these two case studies demonstrate 
that eMatchSite effectively recognizes binding site similarity and constructs biologically 
correct sequence order-independent alignments for pockets inferred by eFindSite from 
ligand-free protein structures.
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Portions of this research were conducted with high-performance computational resources provided by Louisiana 
State University (HPC@LSU, http://www.hpc.lsu.edu).
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Web submission form for the eMatchSite server. Fields marked with red asterisks are 
mandatory.
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Result page for the eMatchSite webserver. (a) Job information and numerical scores for 
pocket similarity, (b) AstexViewer applet showing the superposition of target pockets 
according to the constructed sequence order-independent alignment, (c) a list of aligned 
residue pairs and the corresponding numerical scores, and (d) the download section.
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Ligand binding pockets annotated with eFindSite. Target structures are shown as transparent 
gray cartoons, whereas binding residues are rendered as the molecular surface for (a) BFD, 
(b) OXC, and (c) hE1b. Binding sites in BFD, OXC and hE1b are colored in orange, pink 
and cyan, respectively. ThTDP ligands bound to the target structures are shown as sticks 
colored by the atom type (carbon – green, nitrogen – blue, oxygen – red, sulfur – yellow, 
phosphorus – tan).
Brylinski Page 12














Accuracy of the prediction of inter-residue distances by eMatchSite. Correlation between 
real distances upon the superposition of ThTDP ligands and those predicted by eMatchSite 
for target protein structures is shown for (a) BFD/OXC and (b) BFD/hE1b pairs. Dark gray 
triangles show residue pairs from the reference alignment.
Brylinski Page 13














Chemical correlation between ThTDP binding sites by eMatchSite. Rank correlation is 
plotted for a non-redundant subset of the ZINC library ranked using fingerprint-based virtual 
screening against a pair of target binding sites, (a) BFD/OXC and (b) BFD/hE1b.
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Sequence order-independent alignments of ThTDP binding sites by eMatchSite. (a, b) 
Protein structures are superposed according to the local alignment of their binding sites with 
the Cα atoms of binding residues shown as solid balls. (c, d) Relative orientation of ThTDP 
ligands upon the local alignment of target binding sites. (a, c) BFD/OXC and (b, d) BFD/
hE1b. BFD, OXC and hE1b are colored in orange, pink and cyan, respectively.
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Global and local structure similarity between the target BFD and off-targets OXC and hE1b.
Target/off-target
Global similarity Local similarity
Sequence identity TM-score Pocket RMSD Ligand RMSD
BFD/OXC 25% 0.85 3.18 Å 0.88 Å
BFD/hE1b 25% 0.35 2.72 Å 0.89 Å















Sequence order-independent alignments constructed by eMatchSite for BFD/OXC and BFD/hE1b. Distances 
between the aligned Cα atoms of BFD and either OXC or hE1b are measured upon the superposition of 
binding sites.
BFD OXC hE1b
position position distance [Å] position distance [Å]
S375 G394 3.23 - -
T376 A395 1.07 Y108 3.67
S377 N396 1.52 R109 3.19
G400 G420 2.03 S157 0.43
G401 V421 1.97 P158 0.79
L402 M422 0.61 L159 0.86
G426 G445 0.94 G187 1.19
D427 D446 1.32 E188 1.07
G428 S447 1.38 G189 0.90
S429 A448 0.95 A190 0.71
Y432 F451 0.48 E193 0.62
T456 G479 3.48 Y219 1.57
Y457 G475 2.47 A220 1.34
G458 K478 2.35 N217 5.47
A459 Y477 1.75 H286 3.08
L460 I476 4.31 I221 2.83
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